Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

2012 The Lancet 798 citations

Keywords

MedicineDengue feverDengue vaccinePlaceboSerotypeVaccine efficacyDengue virusPopulationRandomized controlled trialVirologyVaccinationInternal medicineImmunologyEnvironmental healthAlternative medicine

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
article
Volume
380
Issue
9853
Pages
1559-1567
Citations
798
Access
Closed

External Links

Citation Metrics

798
OpenAlex

Cite This

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. (2012). Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet , 380 (9853) , 1559-1567. https://doi.org/10.1016/s0140-6736(12)61428-7

Identifiers

DOI
10.1016/s0140-6736(12)61428-7